Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture

E-ISSN： 1097-4644|119|2|1381-1391

ISSN： 0730-2312

Source： JOURNAL OF CELLULAR BIOCHEMISTRY, Vol.119, Iss.2, 2018-02, pp. : 1381-1391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neural Stem Cells Secreting Anti‐HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases

STEM CELLS, Vol. 1066-5099, Iss. 10, 2015-10 ,pp. : 2985-2994

John Wiley & Sons Inc

Access to resources Recommend Favorite

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

By Lammers Philip Criscitiello Carmen Curigliano Giuseppe Jacobs Ira

Pharmaceuticals, Vol. 7, Iss. 9, 2014-09 ,pp. : 943-953

MDPI

Access to resources Recommend Favorite

Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling

By Akl Mohamed R. Ayoub Nehad M. Ebrahim Hassan Y. Mohyeldin Mohamed M. Orabi Khaled Y. Foudah Ahmed I. El Sayed Khalid A.

Marine Drugs, Vol. 13, Iss. 1, 2015-01 ,pp. : 288-311

MDPI

Access to resources Recommend Favorite

HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells

By Yamaguchi Haruka Hayama Kazuhide Sasagawa Ichiro Okada Yasuo Kawase Tomoyuki Tsubokawa Norio Tsuchimochi Makoto

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 908-908

MDPI

Access to resources Recommend Favorite

Cancer Stem Cells in Breast Cancer

By Takahashi Ryou-u Takeshita Fumitaka Fujiwara Tomohiro Ono Makiko Ochiya Takahiro

Cancers, Vol. 3, Iss. 1, 2011-03 ,pp. : 1311-1328

MDPI

Access to resources Recommend Favorite